NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
SYNOLIGO BIOTECHNOLOGIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
12/31/2024
Trademark type
Combined
Nice classes
1, 5, 40, 42
Filing date
02/05/2024
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
06/30/2022
First use in commerce
01/04/2023
Drawing code
3
Owner type
03
Owner location
Morrisville, NC
Examiner
GAGLIARDI, JEANINE
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of a design of a double stranded DNA forming the left side of the first letter "O" from the word "SYNOLIGO", and that word is positioned on top of the upper-case word "BIOTECHNOLOGIES".
Holders and representatives
Holders
Synoligo Biotechnologies, Inc.
Representatives
Synoligo Biotechnologies, Inc.
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and chemical preparationsoligonucleotidefor research and diagnostic and/or therapeutic use other than for medical or veterinary purposes; nucleic acid reagents for diagnostic purposes except for medical or veterinary purposes
Class 5
Nucleic acid reagents for medicalveterinarymedical and veterinary diagnostic purposes; Chemicals and chemical preparations for therapeutic medical and veterinary purposes
Class 40
Custom oligonucleotide manufacturing for researchdiagnosticstherapeutic applications in the healthcareveterinaryagriculture industry
Class 42
Chemical engineering in the nature of custom synthesis of natural or modified DNA/RNA oligonucleotidesincluding chimeraantisenseprobesprimers with or without modifications such as linkerspacersconjugationsat different scales for researchdiagnosticstherapeutic purposes; new product designresearchdevelopment consulting services in the field of DNA/RNA with or without modifications for researchdiagnosticstherapeutic applications in the healthcareveterinaryagriculture industry
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/04/2024
GNRT
NON-FINAL ACTION E-MAILED
09/04/2024
CNRT
NON-FINAL ACTION WRITTEN
09/04/2024
DOCK
ASSIGNED TO EXAMINER
08/28/2024
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
06/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/02/2024
NWAP
NEW APPLICATION ENTERED
02/05/2024
Continuous trademark protection
Get notified about every new filing that threatens SYNOLIGO BIOTECHNOLOGIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.